DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer research, notably in the contexts of glioblastoma and triple-negative breast cancer [1].
Molecular Weight:
1223.34
Purity:
98.00%
Formula:
C58H78N16O14
* VAT and and shipping costs not included. Errors and price changes excepted